CHRISTINE LEE: Open Payments
NPI 1609331529 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $171 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Boston Scientific Corporation | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
Products named: VRAYLAR, TRINTELLIX, FANAPT, REXULTI, Varithena Administration Pack, Auvelity, Qelbree.
Industry payments across TX — which companies pay providers there.
